Fuji Pharma Ratios and Metrics

Market cap in millions EUR. Fiscal year is October - September.

Millions EUR. Fiscal year is Oct - Sep.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jan '26 Jan 30, 2026	Sep '25 Sep 30, 2025	Sep '24 Sep 30, 2024	Sep '23 Sep 30, 2023	Sep '22 Sep 30, 2022	Sep '21 Sep 30, 2021
Market Capitalization	254	217	194	179	177	220
Market Cap Growth	7.26%	12.11%	8.06%	1.24%	-19.45%	-30.05%
Enterprise Value	384	359	358	342	324	287
Last Close Price	10.30	8.85	7.76	6.87	6.56	8.10
PE Ratio	14.73	12.57	5.04	8.25	9.32	11.68
PS Ratio	0.86	0.73	0.67	0.69	0.71	0.84
PB Ratio	0.94	0.80	0.68	0.69	0.70	0.87
P/TBV Ratio	1.34	1.14	0.94	0.92	0.99	0.94
P/FCF Ratio	11.57	9.87	22.54	-	-	12.89
P/OCF Ratio	7.62	6.50	7.46	14.78	-	4.74
EV/Sales Ratio	1.36	1.21	1.24	1.32	1.30	1.09
EV/EBITDA Ratio	7.86	6.97	7.56	7.85	7.04	6.79
EV/EBIT Ratio	14.10	12.50	14.72	14.01	12.15	11.06
EV/FCF Ratio	17.44	16.33	41.61	-	-	16.81
Debt / Equity Ratio	0.66	0.66	0.64	0.70	0.69	0.57
Debt / EBITDA Ratio	3.45	3.45	3.87	4.21	3.77	3.42
Debt / FCF Ratio	8.10	8.10	21.31	-	-	8.47
Asset Turnover	0.56	0.56	0.53	0.51	0.51	0.54
Inventory Turnover	1.58	1.58	1.51	1.39	1.50	1.70
Quick Ratio	0.82	0.82	0.66	0.63	0.68	1.10
Current Ratio	1.55	1.55	1.19	1.31	1.45	1.73
Return on Equity (ROE)	6.49%	6.49%	14.17%	8.92%	7.87%	6.70%
Return on Assets (ROA)	3.40%	3.40%	2.77%	3.00%	3.38%	3.32%
Return on Invested Capital (ROIC)	5.32%	5.32%	4.18%	4.84%	5.59%	5.95%
Return on Capital Employed (ROCE)	8.00%	8.00%	7.20%	6.90%	7.30%	7.60%
Earnings Yield	6.79%	7.96%	19.86%	12.12%	10.73%	8.56%
FCF Yield	8.65%	10.13%	4.44%	-4.98%	-22.91%	7.76%
Dividend Yield	2.63%	2.96%	3.43%	3.41%	3.76%	2.77%
Payout Ratio	34.53%	34.53%	15.82%	26.17%	27.04%	33.18%
Buyback Yield / Dilution	-0.38%	-0.38%	-0.04%	-0.03%	9.58%	13.77%
Total Shareholder Return	2.25%	2.58%	3.39%	3.37%	13.34%	16.54%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.